These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 12024156)

  • 1. Pyloric injection of botulinum toxin for treatment of diabetic gastroparesis.
    Ezzeddine D; Jit R; Katz N; Gopalswamy N; Bhutani MS
    Gastrointest Endosc; 2002 Jun; 55(7):920-3. PubMed ID: 12024156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The treatment of diabetic gastroparesis with botulinum toxin injection of the pylorus.
    Lacy BE; Crowell MD; Schettler-Duncan A; Mathis C; Pasricha PJ
    Diabetes Care; 2004 Oct; 27(10):2341-7. PubMed ID: 15451898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoscopic pyloric injection of botulinum toxin A for the treatment of refractory gastroparesis.
    Bromer MQ; Friedenberg F; Miller LS; Fisher RS; Swartz K; Parkman HP
    Gastrointest Endosc; 2005 Jun; 61(7):833-9. PubMed ID: 15933684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of idiopathic gastroparesis with injection of botulinum toxin into the pyloric sphincter muscle.
    Miller LS; Szych GA; Kantor SB; Bromer MQ; Knight LC; Maurer AH; Fisher RS; Parkman HP
    Am J Gastroenterol; 2002 Jul; 97(7):1653-60. PubMed ID: 12135014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of endoscopic pyloric therapies for patients with nausea and vomiting and functional obstructive gastroparesis.
    Wellington J; Scott B; Kundu S; Stuart P; Koch KL
    Auton Neurosci; 2017 Jan; 202():56-61. PubMed ID: 27460691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyloric sphincter characteristics using EndoFLIP
    Saadi M; Yu D; Malik Z; Parkman HP; Schey R
    Rev Gastroenterol Mex (Engl Ed); 2018; 83(4):375-384. PubMed ID: 29709494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin A for the treatment of delayed gastric emptying.
    Friedenberg FK; Palit A; Parkman HP; Hanlon A; Nelson DB
    Am J Gastroenterol; 2008 Feb; 103(2):416-23. PubMed ID: 18070232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endoscopic pyloric injection of botulinum toxin-A for the treatment of postvagotomy gastroparesis.
    Reddymasu SC; Singh S; Sankula R; Lavenbarg TA; Olyaee M; McCallum RW
    Am J Med Sci; 2009 Mar; 337(3):161-4. PubMed ID: 19174691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyloric sphincter therapy: botulinum toxin, stents, and pyloromyotomy.
    Clarke JO; Snape WJ
    Gastroenterol Clin North Am; 2015 Mar; 44(1):127-36. PubMed ID: 25667028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyloric distensibility measurement predicts symptomatic response to intrapyloric botulinum toxin injection.
    Desprez C; Melchior C; Wuestenberghs F; Zalar A; Jacques J; Leroi AM; Gourcerol G
    Gastrointest Endosc; 2019 Nov; 90(5):754-760.e1. PubMed ID: 31028783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endoscopic intrapyloric injection of botulinum toxin A in the treatment of children with gastroparesis: a retrospective, open-label study.
    Rodriguez L; Rosen R; Manfredi M; Nurko S
    Gastrointest Endosc; 2012 Feb; 75(2):302-9. PubMed ID: 22248598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with symptom response to pyloric injection of botulinum toxin in a large series of gastroparesis patients.
    Coleski R; Anderson MA; Hasler WL
    Dig Dis Sci; 2009 Dec; 54(12):2634-42. PubMed ID: 19184429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyloric injection of botulinum toxin for the treatment of refractory GERD accompanied with gastroparesis: a preliminary report.
    Mirbagheri SA; Sadeghi A; Amouie M; Mansouri S; Forootan M; Rashidi A; Abouzari M
    Dig Dis Sci; 2008 Oct; 53(10):2621-6. PubMed ID: 18256933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraoperative pyloric botulinum toxin injection during Ivor-Lewis gastroesophagectomy to prevent delayed gastric emptying.
    Tham JC; Nixon M; Ariyarathenam AV; Humphreys L; Berrisford R; Wheatley T; Sanders G
    Dis Esophagus; 2019 Jun; 32(6):. PubMed ID: 30561584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum Toxin Injection for Treatment of Gastroparesis.
    Pasricha TS; Pasricha PJ
    Gastrointest Endosc Clin N Am; 2019 Jan; 29(1):97-106. PubMed ID: 30396531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New therapeutic approaches to diabetic gastroparesis].
    Hummel M; Geigenberger G; Brand J; Ziegler AG; Füchtenbusch M
    Med Klin (Munich); 2008 Jul; 103(7):514-8. PubMed ID: 18604486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastric per-oral endoscopic myotomy versus pyloric injection of botulinum toxin for the treatment of gastroparesis: our institutional experience and a systematic review of the literature.
    Tran D; Leeds SG; Fair L; Fang J; Rubarth C; McGowan T; Ramakrishnan S; Ogola G; Aladegbami B; Ward MA
    Surg Endosc; 2023 Sep; 37(9):7280-7287. PubMed ID: 37430121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin for prevention of delayed gastric emptying after esophagectomy.
    Bagheri R; Fattahi SH; Haghi SZ; Aryana K; Aryanniya A; Akhlaghi S; Riyabi FN; Sheibani S
    Asian Cardiovasc Thorac Ann; 2013 Dec; 21(6):689-92. PubMed ID: 24569327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastroparesis is common after lung transplantation and may be ameliorated by botulinum toxin-A injection of the pylorus.
    Hooft N; Smith M; Huang J; Bremner R; Walia R
    J Heart Lung Transplant; 2014 Dec; 33(12):1314-6. PubMed ID: 25443873
    [No Abstract]   [Full Text] [Related]  

  • 20. Botulinum toxin type A for the treatment of gastroparesis in Parkinson's disease patients.
    Gil RA; Hwynn N; Fabian T; Joseph S; Fernandez HH
    Parkinsonism Relat Disord; 2011 May; 17(4):285-7. PubMed ID: 21296606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.